{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Possibly Marketed Outside US
Source:
NCT01557140: Phase 4 Interventional Completed Chagas Cardiomyopathy
(2003)
Source URL:
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Source:
NCT03190304: Phase 4 Interventional Completed Heart Failure
(2017)
Source URL:
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Source:
NCT00378729: Phase 4 Interventional Unknown status Polycystic Ovary Syndrome
(2006)
Source URL:
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Source:
NCT01151735: Phase 4 Interventional Withdrawn Hereditary Angioedema
(2010)
Source URL:
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Source:
NCT00555087: Phase 4 Interventional Unknown status Erectile Dysfunction
(2007)
Source URL:
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Source:
NCT02333591: Phase 4 Interventional Completed Coronary Microvascular Dysfunction
(2016)
Source URL:
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Source:
NCT04435574: Phase 4 Interventional Completed Anemia, Iron Deficiency
(2018)
Source URL:
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Source:
NCT00220987: Phase 4 Interventional Completed Hyperglycemia
(2005)
Source URL:
Class:
PROTEIN
